These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 25928069)

  • 21. Synthetic cathinones: a new public health problem.
    Karila L; Megarbane B; Cottencin O; Lejoyeux M
    Curr Neuropharmacol; 2015 Jan; 13(1):12-20. PubMed ID: 26074740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Re: "Spice, bath salts, and the U.S. Military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces".
    Platteborze PL; Martin TM
    Mil Med; 2013 Jan; 178(1):v. PubMed ID: 23356108
    [No Abstract]   [Full Text] [Related]  

  • 23. Emerging drugs of abuse.
    Nelson ME; Bryant SM; Aks SE
    Emerg Med Clin North Am; 2014 Feb; 32(1):1-28. PubMed ID: 24275167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prevalence of new psychoactive substances in biological material - a three-year review of casework in Poland.
    Adamowicz P; Gieroń J; Gil D; Lechowicz W; Skulska A; Tokarczyk B
    Drug Test Anal; 2016 Jan; 8(1):63-70. PubMed ID: 26666629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergence and properties of spice and bath salts: a medicinal chemistry perspective.
    Lewin AH; Seltzman HH; Carroll FI; Mascarella SW; Reddy PA
    Life Sci; 2014 Feb; 97(1):9-19. PubMed ID: 24113072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Designer drugs: mechanism of action and adverse effects.
    Luethi D; Liechti ME
    Arch Toxicol; 2020 Apr; 94(4):1085-1133. PubMed ID: 32249347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The New Designer Drug Wave: A Clinical, Toxicological, and Legal Analysis.
    Abbott R; Smith DE
    J Psychoactive Drugs; 2015; 47(5):368-71. PubMed ID: 26579784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spicing things up: synthetic cannabinoids.
    Spaderna M; Addy PH; D'Souza DC
    Psychopharmacology (Berl); 2013 Aug; 228(4):525-40. PubMed ID: 23836028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recreational drugs: the complication's pleasure?].
    Joye F; Donzé N; Frochaux V; Niquille M; Selz Amaudruz F
    Rev Med Suisse; 2013 Aug; 9(394):1454-60. PubMed ID: 24024389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bath salts and other emerging toxins.
    Thornton MD; Baum CR
    Pediatr Emerg Care; 2014 Jan; 30(1):47-52; quiz 53-5. PubMed ID: 24378862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergence of new classes of recreational drugs-synthetic cannabinoids and cathinones.
    Khullar V; Jain A; Sattari M
    J Gen Intern Med; 2014 Aug; 29(8):1200-4. PubMed ID: 24553958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging trends in the abuse of designer drugs and their catastrophic health effects: update on chemistry, pharmacology, toxicology and addiction potential.
    Rapaka RS; Purohit V; Schnur P; Rutter J
    Life Sci; 2014 Feb; 97(1):1. PubMed ID: 24529194
    [No Abstract]   [Full Text] [Related]  

  • 33. Synthetic cannabinoid and cathinone use among US soldiers.
    Berry-Cabán CS; Kleinschmidt PE; Rao DS; Jenkins J
    US Army Med Dep J; 2012; ():19-24. PubMed ID: 23007932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Designer drugs. Patients may be using synthetic cannabinoids more than you think.
    Lisi DM
    JEMS; 2014 Sep; 39(9):56-9. PubMed ID: 25322519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Changing Drug Culture: Emerging Drugs of Abuse and Legal Highs.
    Albertson TE; Chenoweth JA; Colby DK; Sutter ME
    FP Essent; 2016 Feb; 441():18-24. PubMed ID: 26881769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic cathinones: "a khat and mouse game".
    Katz DP; Bhattacharya D; Bhattacharya S; Deruiter J; Clark CR; Suppiramaniam V; Dhanasekaran M
    Toxicol Lett; 2014 Sep; 229(2):349-56. PubMed ID: 24973490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel psychoactive substances.
    Krabseth HM; Tuv SS; Strand MC; Karinen RA; Wiik E; Vevelstad MS; Westin AA; Øiestad EL; Vindenes V
    Tidsskr Nor Laegeforen; 2016 May; 136(8):714-7. PubMed ID: 27143461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical toxicology of newer recreational drugs.
    Hill SL; Thomas SH
    Clin Toxicol (Phila); 2011 Oct; 49(8):705-19. PubMed ID: 21970769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of use and acute toxicity associated with the use of NBOMe drugs.
    Wood DM; Sedefov R; Cunningham A; Dargan PI
    Clin Toxicol (Phila); 2015 Feb; 53(2):85-92. PubMed ID: 25658166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nephrotoxic effects of designer drugs: synthetic is not better!
    Luciano RL; Perazella MA
    Nat Rev Nephrol; 2014 Jun; 10(6):314-24. PubMed ID: 24662435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.